ISOFORM ONCOLOGY LTD

Active Stevenage

Research and experimental development on biotechnology

Research and experimental development on biotechnology
I

ISOFORM ONCOLOGY LTD

Research and experimental development on biotechnology

Founded 12 Oct 2024 Active Stevenage, England website.com
Research and experimental development on biotechnology
Accounts Due 12 Jul 2026 1 month remaining
Confirmation Submitted 24 Oct 2025 Next due 25 Oct 2026 5 months remaining
Net assets N/A
Total assets N/A
Total Liabilities N/A
Charges None No charges registered

Contact & Details

Contact

Registered Address

Stevenage Bioscience Catalyst Gunnels Wood Road Stevenage SG1 2FX England

Website

www.example.com

Full company profile for ISOFORM ONCOLOGY LTD (16014187), an active company based in Stevenage, England. Incorporated 12 Oct 2024. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Awaiting first accounts
For period ending 31 October 2025
Due by 12 July 2026 1 month remaining

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 44,117 Shares £250k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
20 Jun 202544,117£250k£5.67

Officers

Officers

3 active
Status
Emilie Claudine Jennifer SyedDirectorFrench,bangladeshiEngland4430 May 2025Active
Lee Douglas LarcombeDirectorEnglishEngland4912 Oct 2024Active
Sarah Louise MorganDirectorWelshEngland4912 Oct 2024Active

Shareholders

Shareholders (3)

Sarah Morgan
41.0%
100,000
Lee Larcombe
41.0%
100,000

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Lee Douglas Larcombe

English

Active
Notified 12 Oct 2024
Residence England
DOB October 1976
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Sarah Louise Morgan

Welsh

Active
Notified 12 Oct 2024
Residence England
DOB June 1976
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Oct 2025Confirmation StatementConfirmation statement made on 11 Oct 2025 with updates
24 Oct 2025OfficersChange to director Dr Emilie Claudine Jennifer Syed on 11 Jul 2025
13 Aug 2025CapitalAllotment of shares (GBP 2.44117) on 20 Jun 2025
11 Jul 2025AddressChange Registered Office Address Company With Date Old Address New Address
20 Jun 2025CapitalCapital Alter Shares Subdivision
24 Oct 2025 Confirmation Statement

Confirmation statement made on 11 Oct 2025 with updates

24 Oct 2025 Officers

Change to director Dr Emilie Claudine Jennifer Syed on 11 Jul 2025

13 Aug 2025 Capital

Allotment of shares (GBP 2.44117) on 20 Jun 2025

11 Jul 2025 Address

Change Registered Office Address Company With Date Old Address New Address

20 Jun 2025 Capital

Capital Alter Shares Subdivision

Recent Activity

Latest Activity

Confirmation statement made on 11 Oct 2025 with updates

6 months ago on 24 Oct 2025

Change to director Dr Emilie Claudine Jennifer Syed on 11 Jul 2025

6 months ago on 24 Oct 2025

Allotment of shares (GBP 2.44117) on 20 Jun 2025

9 months ago on 13 Aug 2025

Change Registered Office Address Company With Date Old Address New Address

10 months ago on 11 Jul 2025

Capital Alter Shares Subdivision

11 months ago on 20 Jun 2025